Sign In
Get Clay Free →

Suggestions

    Sarah Frew

    Life sciences consultant specializing in the strategic development of cellular and gene therapies.

    Sarah E Frew is a seasoned professional with extensive expertise in the global life sciences industry, particularly in biotechnology and pharmaceutical corporate development and strategy.

    Her skill set includes business development, alliance management, fundraising, licensing and partnering negotiations, business operations, scientific diligence, and corporate communications.

    Sarah holds an Executive Management Certificate in Launching New Ventures from Harvard Business School, a Certificate in MBA Essentials for Managers from the University of Toronto - Rotman School of Management, an MBA in Healthcare Management from the University of Pennsylvania - The Wharton School, a PhD in Cancer Biology from the Massachusetts Institute of Technology, and a BS in Biological Sciences from Carnegie Mellon University.

    Currently, Sarah serves as the Managing Partner at Go Far Advisors, bringing her wealth of experience to the table. Previously, she held leadership positions at reputable organizations such as Penn Center for Innovation at the University of Pennsylvania, Tetralogic Pharmaceuticals, Commons Capital, Genzyme, and the McLaughlin-Rotman Centre for Global Health at the University Health Network, University of Toronto.

    With a diverse background encompassing both hands-on scientific research and strategic business development, Sarah E Frew has constantly demonstrated a strong commitment to driving innovation and growth in the life sciences sector.

    Related Questions

    What specific projects has Sarah E Frew led at Go Far Advisors?
    How did Sarah E Frew transition from meditation teaching to strategic consulting?
    What are some notable achievements of Sarah E Frew in the life sciences industry?
    How does Sarah E Frew's experience at Amazon Web Services influence her current role?
    What is the focus of Go Far Advisors under Sarah E Frew's leadership?